Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brechignac

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Rheumatology|December 1, 1996
Tumoral joint involvement in multiple myeloma and Waldenström's macroglobulinemia--report of 4 casesS Roux, J P Fermand, S Brechignac, et al.
The American Journal of Medicine|June 1, 1990
Capillary microscopy during eosinophilic fasciitis in 15 patients: distinction from systemic sclerodermaS Herson, S Brechignac, J C Piette, et al.
Annales De Medecine Interne|January 1, 1989
[Ungueal capillaroscopy in fasciitis with eosinophilia: a distinctive feature of systemic scleroderma. Apropos of 15 cases]S Herson, S Brechignac, J C Piette, et al.
World Journal of Gastroenterology|November 26, 2008
Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritusMaud Lemoine, Aurelie Revaux, Claire Francoz, et al.
Journal of Environmental Radioactivity|September 6, 2003
Protection of the environment in the 21st century: radiation protection of the biosphere including humankind. Statement of the International Union of RadioecologyF Brechignac, G Polikarpov, D H Oughton, et al.
Leukemia Research|March 5, 2015
Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failureStéphanie Harel, Amina Cherait, Céline Berthon, et al.
British Journal of Haematology|May 10, 2013
Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patientsLaurent Pascal, Odile Beyne-Rauzy, Sabine Brechignac, et al.
Leukemia Research|February 5, 2010
Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies)Christian Rose, Sabine Brechignac, Dominique Vassilief, et al.
Ejhaem|March 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World AnalysisThomas Hueso, Grégory Lazarian, Paul Chauvet, et al.
International Journal of Clinical Practice|September 7, 2021
AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of "monoclonal gammopathy of inflammatory significance"?Alexandre Terré, Magali Colombat, Alexandre Cez, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Rheumatology|December 1, 1996
Tumoral joint involvement in multiple myeloma and Waldenström's macroglobulinemia--report of 4 casesS Roux, J P Fermand, S Brechignac, et al.
The American Journal of Medicine|June 1, 1990
Capillary microscopy during eosinophilic fasciitis in 15 patients: distinction from systemic sclerodermaS Herson, S Brechignac, J C Piette, et al.
Annales De Medecine Interne|January 1, 1989
[Ungueal capillaroscopy in fasciitis with eosinophilia: a distinctive feature of systemic scleroderma. Apropos of 15 cases]S Herson, S Brechignac, J C Piette, et al.
World Journal of Gastroenterology|November 26, 2008
Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritusMaud Lemoine, Aurelie Revaux, Claire Francoz, et al.
Journal of Environmental Radioactivity|September 6, 2003
Protection of the environment in the 21st century: radiation protection of the biosphere including humankind. Statement of the International Union of RadioecologyF Brechignac, G Polikarpov, D H Oughton, et al.
Leukemia Research|March 5, 2015
Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failureStéphanie Harel, Amina Cherait, Céline Berthon, et al.
British Journal of Haematology|May 10, 2013
Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patientsLaurent Pascal, Odile Beyne-Rauzy, Sabine Brechignac, et al.
Leukemia Research|February 5, 2010
Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies)Christian Rose, Sabine Brechignac, Dominique Vassilief, et al.
Ejhaem|March 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World AnalysisThomas Hueso, Grégory Lazarian, Paul Chauvet, et al.
International Journal of Clinical Practice|September 7, 2021
AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of "monoclonal gammopathy of inflammatory significance"?Alexandre Terré, Magali Colombat, Alexandre Cez, et al.
Pageof 6